- Home
- COSM vs ADXN Comparison
COSM vs ADXN Comparison
Compare COSM & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- ADXN
- Stock Information
- Founded
- COSM 2009
- ADXN 2002
- Country
- COSM Greece
- ADXN Switzerland
- Employees
- COSM N/A
- ADXN N/A
- Industry
- COSM Other Pharmaceuticals
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- COSM Health Care
- ADXN Health Care
- Exchange
- COSM Nasdaq
- ADXN Nasdaq
- Market Cap
- COSM 8.2M
- ADXN 7.5M
- IPO Year
- COSM 2013
- ADXN N/A
- Fundamental
- Price
- COSM $0.40
- ADXN $7.60
- Analyst Decision
- COSM
- ADXN Strong Buy
- Analyst Count
- COSM 0
- ADXN 1
- Target Price
- COSM N/A
- ADXN $30.00
- AVG Volume (30 Days)
- COSM 334.1K
- ADXN 8.7K
- Earning Date
- COSM 04-16-2025
- ADXN 06-05-2025
- Dividend Yield
- COSM N/A
- ADXN N/A
- EPS Growth
- COSM N/A
- ADXN N/A
- EPS
- COSM N/A
- ADXN 0.06
- Revenue
- COSM $54,426,402.00
- ADXN $701,260.00
- Revenue This Year
- COSM $28.14
- ADXN N/A
- Revenue Next Year
- COSM N/A
- ADXN N/A
- P/E Ratio
- COSM N/A
- ADXN $0.99
- Revenue Growth
- COSM 1.97
- ADXN N/A
- 52 Week Low
- COSM $0.28
- ADXN $6.51
- 52 Week High
- COSM $1.58
- ADXN $17.05
- Technical
- Relative Strength Index (RSI)
- COSM 48.76
- ADXN 52.85
- Support Level
- COSM $0.28
- ADXN $6.75
- Resistance Level
- COSM $0.39
- ADXN $8.20
- Average True Range (ATR)
- COSM 0.05
- ADXN 0.46
- MACD
- COSM 0.01
- ADXN 0.06
- Stochastic Oscillator
- COSM 71.45
- ADXN 64.50
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.